Midazolam Impurities and its Related Products

Displaying 8 results of Midazolam Impurities

Midazolam is a benzodiazepine medication used to treat anxiety and insomnia. However, like all drugs, it may contain impurities that can affect its potency and safety. Midazolam impurities can be the result of the manufacturing process or storage conditions. These impurities can have harmful effects on the body, including allergic reactions, gastrointestinal issues, and even organ damage. It is important to monitor midazolam impurities to ensure the drug's efficacy and safety for patients.


MIDAZOLAM IMPURITIES, IMPURITIES
(2-(5-(Aminomethyl)-2-methyl-1H-imidazol-1-yl)-5-chlorophenyl)(2-fluorophenyl)methanone Dihydrochloride


CAT No. : CS-O-39635
Mol F. : C18H17Cl3FN3O
Mol W. : 416.7 g/mol
Cas No. : 59468-73-4
Stock : Enquire

MIDAZOLAM IMPURITIES, IMPURITIES
Midazolam glycol ether


CAT No. : CS-O-44080
Mol F. : C22H22ClN3O3
Mol W. : 411.88 g/mol
Cas No. : Not Available
Stock : Enquire

MIDAZOLAM IMPURITIES, IMPURITIES
midazolam Nitromethylene compound


CAT No. : CS-O-34086
Mol F. : C16H11ClFN3O3
Mol W. : 347.7 g/mol
Cas No. : 60656-76-0
Stock : Enquire

MIDAZOLAM IMPURITIES, IMPURITIES
Midazolam Nitroso Impurity


CAT No. : CS-O-46598
Mol F. : C16H12ClFN4O
Mol W. : 330.7 g/mol
Cas No. : 59467-62-8
Stock : Enquire

MIDAZOLAM IMPURITIES, IMPURITIES
midazolam N-Nitroso N-Oxide Nitromethylene Impurity


CAT No. : CS-O-50048
Mol F. : C16H12ClFN4O4
Mol W. : 378.74 g/mol
Cas No. : Not Available
Stock : Enquire

MIDAZOLAM IMPURITIES, IMPURITIES
N-Nitroso Midazolam EP Impurity A


CAT No. : CS-EO-02601
Mol F. : C₁₈H₁₄ClFN₄O
Mol W. : 356.78 g/mol
Cas No. : 59469-02-2
Stock : IN-Stock

MIDAZOLAM IMPURITIES, IMPURITIES
N-Nitroso Midazolam EP Impurity E


CAT No. : CS-EO-02679
Mol F. : C16H14ClFN4O
Mol W. : 332.8 g/mol
Cas No. : Not Available
Stock : Enquire

MIDAZOLAM IMPURITIES, IMPURITIES
N-Nitroso Midazolam EP Impurity J


CAT No. : CS-EO-02680
Mol F. : C18H16ClFN4O 2(HCl)
Mol W. : Not Available
Cas No. : Not Available
Stock : Enquire